| Financial Year |
March 31 2023 |
| Monetary Funds |
515,909,921.64 |
| Held-for-trading Financial Assets |
360,733,042.08 |
| Notes Receivable |
57,470,737.72 |
| Accounts Receivable |
312,506,495.83 |
| Advances to Suppliers |
875,825.37 |
| Other Receivables |
1,183,685.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
265,621,392.96 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
31,824,180.61 |
| Total Current Assets |
1,616,871,181.08 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
564,256,677.93 |
| Under-construction Projects |
70,395,006.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
56,810,502.31 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
9,366,151.44 |
| Other Non-Current Assets |
2,300,006.22 |
| Sub-Total of Non-Current Assets |
703,128,344.85 |
| Total Assets |
2,319,999,525.93 |
| Short-Term Loans |
153,995,448.84 |
| Trading Financial liabilities |
664,993.50 |
| Notes Payable |
219,772,836.16 |
| Accounts Payable |
301,212,331.65 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
26,401,928.81 |
| Taxes Payable |
5,978,200.11 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
10,567,266.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
36,646.75 |
| Sub-Total of Current Liabilities |
718,946,187.24 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,350,998.72 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
44,100,617.72 |
| Total Liabilities |
763,046,804.96 |
| Paid-In Capital(Or Share Stock) |
142,923,950.00 |
| Capital Surplus |
781,155,434.10 |
| Surplus Reserve |
24,599,630.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
600,975,655.34 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,556,952,720.97 |
| Owner's Equity（Stockholder's Equity） |
1,556,952,720.97 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,319,999,525.93 |
